Partial Thromboplastin Time

Partial Thromboplastin Time is a blood test that looks at how well your blood forms a clot through the intrinsic and common pathways of the clotting system. In the laboratory, chemicals are added to a sample of your plasma to start the clotting process, and the time it takes to clot is measured in seconds. This helps assess the activity of several clotting proteins, including factors VIII, IX, XI, and XII, as well as parts of the final steps of clot formation.

Clinicians often pair this test with the Prothrombin Time/INR to get a fuller picture of your clotting function. The test is commonly used when there are signs of unusual bleeding or bruising, when clots occur without a clear cause, before some procedures, or when certain blood thinners are being used.

Results can help find causes of abnormal bleeding, such as inherited factor deficiencies like hemophilia A or B, or acquired problems from conditions that affect clotting factor production or use. It can also point to the presence of inhibitors that interfere with clotting proteins, including antibodies known as lupus anticoagulants, which can be linked to an increased risk of blood clots.

Your care team may order this test to monitor unfractionated heparin therapy, to check for clotting abnormalities before surgery, or to evaluate unexplained bruising, nosebleeds, heavy menstrual bleeding, or clotting events. Knowing your clotting status helps guide treatment decisions and the safe use of medications that affect clotting. The blood draw is a routine procedure with minimal risk.

A longer clotting time typically suggests that one or more clotting factors are low or not functioning properly, that an inhibitor is interfering with the clotting process, or that a medication affecting clotting is present. Sometimes the time appears prolonged because of an antibody that affects the test but does not cause bleeding, which may instead be associated with a tendency to clot. A shorter time is less common and is usually not clinically important on its own.

Your result is interpreted in the context of your symptoms, medical history, medications, and other lab tests. If the result is unexpected, your clinician may repeat the test to rule out sample issues, perform a mixing study to distinguish factor deficiency from an inhibitor, order specific factor assays, check for lupus anticoagulant, or use anti–factor Xa testing if you are receiving heparin. If you have signs of active bleeding or a new clot, seek medical care promptly while follow-up testing is arranged.